These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 33239166)
1. Development of a nano-luciferase based assay to measure the binding of SARS-CoV-2 spike receptor binding domain to ACE-2. Lima MA; Skidmore M; Khanim F; Richardson A Biochem Biophys Res Commun; 2021 Jan; 534():485-490. PubMed ID: 33239166 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution. Zahradník J; Marciano S; Shemesh M; Zoler E; Harari D; Chiaravalli J; Meyer B; Rudich Y; Li C; Marton I; Dym O; Elad N; Lewis MG; Andersen H; Gagne M; Seder RA; Douek DC; Schreiber G Nat Microbiol; 2021 Sep; 6(9):1188-1198. PubMed ID: 34400835 [TBL] [Abstract][Full Text] [Related]
3. Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction. Brown EEF; Rezaei R; Jamieson TR; Dave J; Martin NT; Singaravelu R; Crupi MJF; Boulton S; Tucker S; Duong J; Poutou J; Pelin A; Yasavoli-Sharahi H; Taha Z; Arulanandam R; Surendran A; Ghahremani M; Austin B; Matar C; Diallo JS; Bell JC; Ilkow CS; Azad T Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668756 [TBL] [Abstract][Full Text] [Related]
4. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries. David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A Molecules; 2021 May; 26(11):. PubMed ID: 34072087 [TBL] [Abstract][Full Text] [Related]
5. Thiol-based chemical probes exhibit antiviral activity against SARS-CoV-2 via allosteric disulfide disruption in the spike glycoprotein. Shi Y; Zeida A; Edwards CE; Mallory ML; Sastre S; Machado MR; Pickles RJ; Fu L; Liu K; Yang J; Baric RS; Boucher RC; Radi R; Carroll KS Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35074895 [TBL] [Abstract][Full Text] [Related]
6. Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry. Azad T; Singaravelu R; Taha Z; Jamieson TR; Boulton S; Crupi MJF; Martin NT; Fekete EEF; Poutou J; Ghahremani M; Pelin A; Nouri K; Rezaei R; Marshall CB; Enomoto M; Arulanandam R; Alluqmani N; Samson R; Gingras AC; Cameron DW; Greer PA; Ilkow CS; Diallo JS; Bell JC Mol Ther; 2021 Jun; 29(6):1984-2000. PubMed ID: 33578036 [TBL] [Abstract][Full Text] [Related]
7. Tinocordiside from Balkrishna A; Pokhrel S; Varshney A Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372 [TBL] [Abstract][Full Text] [Related]
8. An angiotensin-converting enzyme-2-derived heptapeptide GK-7 for SARS-CoV-2 spike blockade. Han S; Zhao G; Wei Z; Chen Y; Zhao J; He Y; He YJ; Gao J; Chen S; Du C; Wang T; Sun W; Huang Y; Wang C; Wang J Peptides; 2021 Nov; 145():170638. PubMed ID: 34419496 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19). Nayak SK Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074 [TBL] [Abstract][Full Text] [Related]
10. Structural characteristics of BtKY72 RBD bound to bat ACE2 reveal multiple key residues affecting ACE2 usage of sarbecoviruses. Su C; He J; Wang L; Hu Y; Cao J; Bai B; Qi J; Gao GF; Yang M; Wang Q mBio; 2024 Sep; 15(9):e0140424. PubMed ID: 39082798 [TBL] [Abstract][Full Text] [Related]
11. Computational design of ultrashort peptide inhibitors of the receptor-binding domain of the SARS-CoV-2 S protein. Pei P; Qin H; Chen J; Wang F; He C; He S; Hong B; Liu K; Qiao R; Fan H; Tong Y; Chen L; Luo SZ Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34180984 [TBL] [Abstract][Full Text] [Related]
12. Withanone from Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804 [TBL] [Abstract][Full Text] [Related]
13. Common cardiac medications potently inhibit ACE2 binding to the SARS-CoV-2 Spike, and block virus penetration and infectivity in human lung cells. Caohuy H; Eidelman O; Chen T; Liu S; Yang Q; Bera A; Walton NI; Wang TT; Pollard HB Sci Rep; 2021 Nov; 11(1):22195. PubMed ID: 34773067 [TBL] [Abstract][Full Text] [Related]
14. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor. Lata S; Akif M J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980 [TBL] [Abstract][Full Text] [Related]
15. Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies. Jena AB; Kanungo N; Nayak V; Chainy GBN; Dandapat J Sci Rep; 2021 Jan; 11(1):2043. PubMed ID: 33479401 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 spike protein favors ACE2 from Bovidae and Cricetidae. Luan J; Jin X; Lu Y; Zhang L J Med Virol; 2020 Sep; 92(9):1649-1656. PubMed ID: 32239522 [TBL] [Abstract][Full Text] [Related]
17. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs. Choudhury A; Mukherjee S J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269 [TBL] [Abstract][Full Text] [Related]
18. Xeno-Nucleic Acid (XNA) 2'-Fluoro-Arabino Nucleic Acid (FANA) Aptamers to the Receptor-Binding Domain of SARS-CoV-2 S Protein Block ACE2 Binding. Alves Ferreira-Bravo I; DeStefano JJ Viruses; 2021 Oct; 13(10):. PubMed ID: 34696413 [TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19. Dakal TC Immunobiology; 2021 Jan; 226(1):152021. PubMed ID: 33232865 [TBL] [Abstract][Full Text] [Related]
20. Cooperative multivalent receptor binding promotes exposure of the SARS-CoV-2 fusion machinery core. Pak AJ; Yu A; Ke Z; Briggs JAG; Voth GA Nat Commun; 2022 Feb; 13(1):1002. PubMed ID: 35194049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]